Home › Attention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder clinical trials recruiting in the U.S.
70 studies for Attention Deficit Hyperactivity Disorder are recruiting participants at sites across the United States.
Does your child have trouble paying attention? This may be a symptom of attention deficit hyperactive disorder (often called ADHD or ADD). Read more.
Cities with the most studies
- Boston, MA10 studies
- Cincinnati, OH8 studies
- Washington, DC7 studies
- Austin, TX6 studies
- Philadelphia, PA6 studies
- Pittsburgh, PA5 studies
- Las Vegas, NV5 studies
- Orlando, FL5 studies
- Los Angeles, CA4 studies
- Durham, NC4 studies
- Jacksonville, FL4 studies
- Irvine, CA4 studies
- Memphis, TN4 studies
- Jackson, MS4 studies
- Baltimore, MD4 studies
- Atlanta, GA4 studies
- Sacramento, CA3 studies
- Seattle, WA3 studies
- Mountain View, CA3 studies
- Portland, OR3 studies
- New York City, NY3 studies
- Harrisburg, PA3 studies
- Little Rock, AR3 studies
- Kendall, FL3 studies
- North Charleston, SC3 studies
- Long Beach, CA3 studies
By state
- Alabama4 studies
- Arkansas4 studies
- California15 studies
- Florida7 studies
- Georgia4 studies
- Kentucky3 studies
- Louisiana3 studies
- Maryland9 studies
- Massachusetts12 studies
- Michigan3 studies
- Mississippi4 studies
- Nevada5 studies
- New Jersey3 studies
- New York6 studies
- North Carolina5 studies
- Ohio9 studies
- Oregon4 studies
- Pennsylvania12 studies
- South Carolina5 studies
- Tennessee4 studies
- Texas8 studies
- Utah3 studies
- Virginia3 studies
- Washington4 studies
Recently updated studies
Role of Theta Frequency Oscillations in Proactive and Reactive Control Processes in Youth With Attention Deficit Hyperactivity Disorder (ADHD) and Obsessive Compulsive Disorder (OCD)
RecruitingObservational studyHealthy volunteers welcome
Ages 10 to 17 · All sexes · Updated Oct 5, 2026 · NCT07566468Augmenting Parent Management Training for Child Temper Outbursts Using a Digital Tool
RecruitingObservational study
Ages 8 to 13 · All sexes · Updated Oct 5, 2026 · NCT07764536Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
RecruitingPhase 4
48 Months – 69 Months · All sexes · Updated Oct 5, 2026 · NCT04781140Impact of Parental Emotion Regulation on the Treatment of ADHD
Recruiting
Ages 5 to 12 · All sexes · Updated Oct 5, 2026 · NCT05299814Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
RecruitingPhase 1/2
Ages 8 to 16 · All sexes · Updated Oct 5, 2026 · NCT05608434Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy
RecruitingObservational study
Ages 8 to 17 · All sexes · Updated Oct 5, 2026 · NCT07640802Developing Brain, Impulsivity and Compulsivity
RecruitingObservational study
Ages 6 to 80 · All sexes · Updated Sep 25, 2026 · NCT04631042Binaural Beats Stimulation for Adults With Attention-Deficit/Hyperactivity Disorder
Recruiting
Ages 18 to 55 · All sexes · Updated Sep 21, 2026 · NCT07793045Fidgeting and Attentional and Emotional Regulation in ADHD
Recruiting
Ages 18 to 30 · All sexes · Updated Sep 15, 2026 · NCT04526600A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 14, 2026 · NCT07759154Treating Young Children With Attention Deficit Hyperactivity Disorder
RecruitingPhase 4
Ages 3 to 5 · All sexes · Updated Sep 14, 2026 · NCT07300956Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
RecruitingPhase 1
Ages 8 to 17 · All sexes · Updated Sep 9, 2026 · NCT07226219Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 8, 2026 · NCT07717892MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal Patients
RecruitingObservational study
Ages 18 to 100 · Women · Updated Sep 8, 2026 · NCT07540585Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Sep 8, 2026 · NCT07717879Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD
Recruiting
Ages 4 to 8 · All sexes · Updated Aug 25, 2026 · NCT07784348Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
RecruitingObservational studyHealthy volunteers welcome
Ages 0 to 20 · All sexes · Updated Aug 21, 2026 · NCT04278404Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Aug 19, 2026 · NCT05776056Smartphone-based Intervention for Young Adults With ADHD
Recruiting
Ages 18 to 25 · All sexes · Updated Aug 18, 2026 · NCT07654205Impact of Short and Mistimed Sleep on Adolescents With ADHD: The Adolescent Attention and Circadian Timing Study
Recruiting
Ages 13 to 17 · All sexes · Updated Aug 17, 2026 · NCT07684417A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 10, 2026 · NCT07755410Virtual Reality Attention Management
Recruiting
Ages 8 to 12 · All sexes · Updated Aug 7, 2026 · NCT03221244Medication Treatment of ADHD in Pediatric Epilepsy
RecruitingPhase 4
Ages 6 to 17 · All sexes · Updated Jul 29, 2026 · NCT07594652Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure
Recruiting
Ages 8 to 12 · All sexes · Updated Jul 16, 2026 · NCT06847165Atomoxetine and Executive Function in PTSD
RecruitingPhase 4Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Jul 7, 2026 · NCT06573970From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.